Impact of modifiable cardiovascular risk factors on mortality after percutaneous coronary intervention: a systematic review and meta-analysis of 100 studies
PK Bundhun, ZJ Wu, MH Chen - Medicine, 2015 - journals.lww.com
Modifiable cardiovascular risk factors such as obesity, hypertension, dyslipidemia, smoking,
diabetes mellitus, and metabolic syndrome can easily give rise to coronary heart disease …
diabetes mellitus, and metabolic syndrome can easily give rise to coronary heart disease …
Long-term prognosis of chronic total occlusion treated by successful percutaneous coronary intervention in patients with or without diabetes mellitus: a systematic …
Y Zhu, S Meng, M Chen, K Liu, R Jia, H Li… - Cardiovascular …, 2021 - Springer
Background Diabetes mellitus (DM) is highly prevalent among patients undergoing
percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Therefore, the …
percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Therefore, the …
Outcomes of chronic total occlusion percutaneous coronary intervention in patients with diabetes: insights from the OPEN CTO registry
AC Salisbury, J Sapontis, JA Grantham, M Qintar… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: Few studies have evaluated the relationship of diabetes with technical success
and periprocedural complications, and no studies have compared patient-reported health …
and periprocedural complications, and no studies have compared patient-reported health …
In-hospital, short-term and long-term adverse clinical outcomes observed in patients with type 2 diabetes mellitus vs non-diabetes mellitus following percutaneous …
X Zhuo, C Zhang, J Feng, S Ouyang, P Niu, Z Dai - Medicine, 2019 - journals.lww.com
Background: Several studies have shown that patients with type 2 diabetes mellitus (T2DM)
have worse clinical outcomes in comparison to patients without diabetes mellitus (DM) …
have worse clinical outcomes in comparison to patients without diabetes mellitus (DM) …
Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention
Background Cardiovascular diseases remain a leading cause of global mortality, particularly
among diabetic patients undergoing percutaneous coronary intervention (PCI). Chronic …
among diabetic patients undergoing percutaneous coronary intervention (PCI). Chronic …
[PDF][PDF] Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes
F Sanguineti, P Garot, S O'Connor, Y Watanabe… - …, 2017 - academia.edu
Aims: Despite technical advancements, long-term outcomes after chronic total occlusion
(CTO) recanalisation remain a subject of debate, especially in diabetic patients. The aim of …
(CTO) recanalisation remain a subject of debate, especially in diabetic patients. The aim of …
Impact of diabetes mellitus on 5-year clinical outcomes in patients with chronic total occlusion lesions
Background Diabetes mellitus (DM) is a major predictor of cardiovascular morbidity and
mortality. However, there are limited data on the impact of DM in patients who have chronic …
mortality. However, there are limited data on the impact of DM in patients who have chronic …
Long term clinical impact of successful recanalization of chronic total occlusion in patients with and without type 2 diabetes mellitus
CT Tsai, WC Huang, HI Teng, YL Tsai… - Cardiovascular …, 2020 - Springer
Background Diabetes mellitus is one of the risk factors for coronary artery disease and
frequently associated with multivessels disease and poor clinical outcomes. Long term …
frequently associated with multivessels disease and poor clinical outcomes. Long term …
Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes
EJ Flores‐Umanzor, PL Cepas‐Guillen… - Catheterization and …, 2021 - Wiley Online Library
Background Chronic total occlusion (CTO) is common in patients with diabetes mellitus.
Data on the long‐term outcomes after treatment of CTOs in this high‐risk population are …
Data on the long‐term outcomes after treatment of CTOs in this high‐risk population are …
Short‐term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new‐generation drug‐eluting stent
NPA Vranken, S Rasoul, JJP Luijkx… - Diabetes/Metabolism …, 2022 - Wiley Online Library
Background The optimal duration of dual antiplatelet therapy (DAPT) in patients with
diabetes mellitus (DM) admitted with acute coronary syndrome (ACS) and treated with a …
diabetes mellitus (DM) admitted with acute coronary syndrome (ACS) and treated with a …